Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City
Alain Borczuk, Steven Salvatore, Surya V. Seshan, et al.
Modern Pathology (2020) Vol. 33, Iss. 11, pp. 2156-2168
Open Access | Times Cited: 450

Showing 1-25 of 450 citing articles:

Features, Evaluation and Treatment Coronavirus (COVID-19)
Marco Cascella, Michael Rajnik, Arturo Cuomo, et al.
StatPearls (2020)
Closed Access | Times Cited: 2803
Severe Covid-19
David Berlin, Roy M. Gulick, Fernando J. Martínez
New England Journal of Medicine (2020) Vol. 383, Iss. 25, pp. 2451-2460
Closed Access | Times Cited: 1403
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
David Halpin, Gerard J. Criner, Alberto Papi, et al.
American Journal of Respiratory and Critical Care Medicine (2020) Vol. 203, Iss. 1, pp. 24-36
Open Access | Times Cited: 642
Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology
Rossana Bussani, Edoardo Schneider, Lorena Zentilin, et al.
EBioMedicine (2020) Vol. 61, pp. 103104-103104
Open Access | Times Cited: 364
Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization
Jenelle Badulak, Marta Velia Antonini, Christine Stead, et al.
ASAIO Journal (2021) Vol. 67, Iss. 5, pp. 485-495
Open Access | Times Cited: 355
Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
Carly G.K. Ziegler, Vincent N. Miao, Anna H. Owings, et al.
Cell (2021) Vol. 184, Iss. 18, pp. 4713-4733.e22
Open Access | Times Cited: 283
Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19)
Abdul Aleem, Abdul Samad, Amy Slenker
(2021) Vol. 01, pp. 01-01
Closed Access | Times Cited: 244
Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience
Clare Bryce, Zachary Grimes, Elisabet Pujadas, et al.
Modern Pathology (2021) Vol. 34, Iss. 8, pp. 1456-1467
Open Access | Times Cited: 221
Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19
Felice D’Agnillo, Kathie‐Anne Walters, Yongli Xiao, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 620
Open Access | Times Cited: 201
COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts
Alison E. John, Chitra Joseph, Gisli Jenkins, et al.
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 228-240
Open Access | Times Cited: 170
The pulmonary pathology of COVID-19
Hans Bösmüller, Matthias S. Matter, Falko Fend, et al.
Virchows Archiv (2021) Vol. 478, Iss. 1, pp. 137-150
Open Access | Times Cited: 168
Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus
Damien J. Downes, Amy Cross, Hua Peng, et al.
Nature Genetics (2021) Vol. 53, Iss. 11, pp. 1606-1615
Open Access | Times Cited: 152
JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy
Sairaj Satarker, Antriya Annie Tom, Roshitha Ann Shaji, et al.
Postgraduate Medicine (2020) Vol. 133, Iss. 5, pp. 489-507
Open Access | Times Cited: 150
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
Paul E. Verweij, Roger J. M. Brüggemann, Élie Azoulay, et al.
Intensive Care Medicine (2021) Vol. 47, Iss. 8, pp. 819-834
Open Access | Times Cited: 140
Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19
James P. Bridges, Eszter K. Vladar, Hua Huang, et al.
Thorax (2021) Vol. 77, Iss. 2, pp. 203-209
Open Access | Times Cited: 137
ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida
Eduardo Oliveira, Amay Parikh, Arnaldo Lopez‐Ruiz, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0249038-e0249038
Open Access | Times Cited: 136
COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options
Larissa E. van Eijk, Mathijs Binkhorst, Arno R. Bourgonje, et al.
The Journal of Pathology (2021) Vol. 254, Iss. 4, pp. 307-331
Open Access | Times Cited: 125
Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities
Bethany Claridge, Jonathan Lozano, Qi Hui Poh, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 124
Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortality
Julio Silva, Carolina Lucas, Maria E. Sundaram, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 109
Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series
Julu Bhatnagar, Joy Gary, Sarah Reagan-Steiner, et al.
The Journal of Infectious Diseases (2021) Vol. 223, Iss. 5, pp. 752-764
Open Access | Times Cited: 108
Symptom Persistence Despite Improvement in Cardiopulmonary Health – Insights from longitudinal CMR, CPET and lung function testing post-COVID-19
Mark Philip Cassar, Elizabeth M. Tunnicliffe, Nayia Petousi, et al.
EClinicalMedicine (2021) Vol. 41, pp. 101159-101159
Open Access | Times Cited: 108
Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19
Courtney Tindle, Mackenzie Fuller, Ayden G. Fonseca, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 105
Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation
Sally Singh, Molly M Baldwin, Enya Daynes, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 8, pp. 709-725
Open Access | Times Cited: 99
Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review
Stefania Caramaschi, Meghan Kapp, Sara Miller, et al.
Modern Pathology (2021) Vol. 34, Iss. 9, pp. 1614-1633
Open Access | Times Cited: 102
Endothelial cell infection and dysfunction, immune activation in severe COVID-19
Zhongnan Qin, Fengming Liu, Robert V. Blair, et al.
Theranostics (2021) Vol. 11, Iss. 16, pp. 8076-8091
Open Access | Times Cited: 99
Page 1 - Next Page

Scroll to top